Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations

Exclusion Criteria

• •Females who are pregnant, nursing or planning pregnancy
• •IOP greater than 36 mmHg at any time point at screening or baseline
• •Diagnosis of angle-closure glaucoma or secondary glaucoma other than capsular or pigmentary glaucoma in either eye
• •Suspected contraindication or hypersensitivity to study medications tafluprost or timolol (e.g. asthma, low pulse) or to wash-out medication brinzolamide
• •Glaucoma filtration surgery or any other ocular surgery (including ocular laser procedures) within 6 months prior to Screening
• •Use of contact lenses at Screening or during the study
• •Presence of any abnormality or significant illness that could be expected to interfere with the patient safety or study parameters
• •Current participation in another clinical trial within the last 30 days